Virginia naloxone maker to launch generic version, drop list price by $3,922

(By Alia Paavola for Becker’s Hospital Review)

A month after Kaleo came under fire for raising the price of its opioid antidote 600 percent to $4,100, the Virginia drugmaker announced it will launch a generic version at a fraction of the cost, according to a STAT news report. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.